In vivo bypass of hemophila A coagulation defect by Factor XIIa implant

Article Abstract:

Administration of recombinant Factor VIIa and Factor IX can overcome the coagulation defects associated with Hemophilia A and B respectively. Researchers have developed a continuous regeneration of Factor VIIa, which had formerly exhibited too short a half-life for clinical use.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

Production of hepatitis B surface antigen in transgenic plants for oral immunization

Article Abstract:

The article presents data showing oral immunogenicity of recombinant hepatitis B surface antigen (HBsAg) in preclinical animal trials.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code:

In vitro selection of necleoprotein enzymes

Article Abstract:

Nucleic acids selected in vitro can catalyze a broad range of reactions even in the absence of proteins.

User Contributions:

Comment about this article or add new information about this topic:

Comment:  (50-4000 characters)

Name:

E-mail:

Security Code: